SEC Company Response from VIVEVE MEDICAL, INC. (VIVE) (CIK 0000879682) — Jan 13, 2021
VIVEVE MEDICAL, INC. (VIVE) (CIK 0000879682)
Date: Jan. 13, 2021 · CIK: 0000879682 · Accession: 0001437749-21-000609
AI Filing Summary & Sentiment
File numbers found in text: 333-251517
Letter
vive20210112_corresp.htm
January 13, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attn: Alan Campbell
RE:
Viveve Medical Inc. (the “Registrant”) – Request for Acceleration
Registration Statement on Form S-1
File No. 333-251517
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P./Alliance Global Partners, as representative of the several underwriters, hereby join in the request of the Registrant for the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on Wednesday, January 13, 2021, or as soon thereafter as reasonably practicable.
We hereby authorize each of Aron Izower and Wendy Grasso of Reed Smith LLP, attorneys for the underwriters, to orally modify or withdraw this request for acceleration.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
A.G.P./ALLIANCE GLOBAL PARTNERS
Show Raw Text
CORRESP 1 filename1.htm vive20210112_corresp.htm January 13, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Attn: Alan Campbell RE: Viveve Medical Inc. (the “Registrant”) – Request for Acceleration Registration Statement on Form S-1 File No. 333-251517 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P./Alliance Global Partners, as representative of the several underwriters, hereby join in the request of the Registrant for the acceleration of the effective date of the above-referenced Registration Statement, so that it will become effective at 5:00 p.m., Eastern Time, on Wednesday, January 13, 2021, or as soon thereafter as reasonably practicable. We hereby authorize each of Aron Izower and Wendy Grasso of Reed Smith LLP, attorneys for the underwriters, to orally modify or withdraw this request for acceleration. Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the securities, as many copies of the preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue. Very truly yours, A.G.P./ALLIANCE GLOBAL PARTNERS By: /s/ Tom Higgins Name: Tom Higgins Title: Managing Director